Evaluation of the Safety and Tolerability of CKD-508 in Healthy Subjects

  • participants needed
  • sponsor
    Chong Kun Dang Pharmaceutical
Updated on 27 September 2022
Accepts healthy volunteers


This study is a first-in-human, randomized, placebo-controlled, 3-part, single ascending dose and multiple ascending dose study. The study is designed to assess the safety, tolerability, PK, and PD of orally administered CKD-508 capsules and tablets in healthy subjects.

Condition Healthy Subjects
Treatment Placebo, Placebo Capsule, Placebo tablet, CKD-508 single dose, CKD-508 multiple dose, CKD-508 Capsule, CKD-508 Tablet
Clinical Study IdentifierNCT04488900
SponsorChong Kun Dang Pharmaceutical
Last Modified on27 September 2022

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note